Tag Archives: CAMCEVI®

EVERSANA and Accord BioPharma Support Launch of CAMCEVI®

EVERSANA and Accord BioPharma announced a partnership to support the recent launch of CAMCEVI® (leuprolide) 42mg injection emulsion for the treatment of advanced prostate cancer in adults